Nicola K. Viebig

Heidelberg University — Germany

Medicine · Health Sciences

25h-index2.3kcitations45works8.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(35), Mosquito-borne diseases and control(22), Complement system in diseases(15), HIV Research and Treatment(10), vaccines and immunoinformatics approaches(7)

Publications45 total

Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials
The Lancet Microbe·2025· 8 citedOpen Access
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
Lab Animal·2023· 2 citedOpen Access
Impact of exposure to malaria and nutritional status on responses to the experimental malaria vaccine ChAd63 MVA ME-TRAP in 5-17 month-old children in Burkina Faso
Frontiers in Immunology·2022· 9 citedOpen Access
A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies
Frontiers in Immunology·2022· 8 citedOpen Access
Asexual Blood-Stage Malaria Vaccine Candidate PfRipr5: Enhanced Production in Insect Cells
Frontiers in Bioengineering and Biotechnology·2022· 14 citedOpen Access
<i>Aotus nancymaae</i> model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
2022· 1 citedOpen Access
Progress and Insights Toward an Effective Placental Malaria Vaccine
Frontiers in Immunology·2021· 39 citedOpen Access
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
The Lancet Infectious Diseases·2020· 122 citedOpen Access
Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool
F1000Research·2020· 3 citedOpen Access
Phase I assessments of first-in-human administration of a novel malaria anti-sporozoite vaccine candidate, R21 in matrix-M adjuvant, in UK and Burkinabe volunteers
2019· 28 citedOpen Access
Pipeline analysis of a vaccine candidate portfolio for diseases of poverty using the Portfolio-To-Impact modelling tool
F1000Research·2019· 1 citedOpen Access
OC 8582 A PHASE IA/B STUDY TO ASSESS SAFETY AND IMMUNOGENICITY OF PLACENTAL MALARIA VACCINE CANDIDATE: PRELIMINARY RESULTS OF THE PRIMALVAC TRIAL
BMJ Global Health·2019Open Access
OC 8552 EFFICACY OF THE CHAD63-MVC ME-TRAP VECTORED MALARIA VACCINE CANDIDATE IN 5–17 MONTHS OLD INFANTS AND CHILDREN IN BURKINA FASO
BMJ Global Health·2019Open Access
Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
EBioMedicine·2019· 26 citedOpen Access
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
PLoS ONE·2018· 92 citedOpen Access
Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development
npj Vaccines·2018· 30 citedOpen Access
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
Frontiers in Immunology·2017· 27 citedOpen Access
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
JCI Insight·2017· 147 citedOpen Access
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
Molecular Therapy·2017· 48 citedOpen Access
IMMUNOGENICITY OF MALARIA-VECTORED VACCINES IS NOT AFFECTED BY CO-ADMINISTRATION WITH ROUTINE EPI VACCINES IN A RANDOMISED CONTROLLED TRIAL IN GAMBIAN INFANTS AND NEONATES
BMJ Global Health·2017Open Access
page 1 of 3Next →

Frequent Co-authors

Adrian V. S. Hill(15), Katie Ewer(15), Odile Leroy(15), Benoît Gamain(13), Rachel Roberts(13), Egeruan B. Imoukhuede(13), Sodiomon B. Sirima(13), Alison M. Lawrie(12), Carly M. Bliss(12), Georgina Bowyer(10), Issa Nébié(10), Kalifa Bojang(9), Alfred B. Tiono(9), Nicholas Anagnostou(8), Arnaud Chêne(8), Muhammed O. Afolabi(8), Alfredo Nicosia(7), Alphonse Ouédraogo(7), Ya Jankey Jagne(7), Artur Scherf(6)